Back to Search
TIA CORBETT, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1912223991Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
5302033614(MI)
Research & Publications (20)
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.
PMID 12795528·Invest New Drugs·2003
4-observational
An experimental and numerical comparison of the rupture locations of an abdominal aortic aneurysm.
PMID 19642790·J Endovasc Ther·2009
4-observational
Experimental modelling of aortic aneurysms: novel applications of silicone rubbers.
PMID 19595622·Med Eng Phys·2009
8-other
A review of the in vivo and in vitro biomechanical behavior and performance of postoperative abdominal aortic aneurysms and implanted stent-grafts.
PMID 18729555·J Endovasc Ther·2008
6-review
Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy.
PMID 18594316·J Thorac Oncol·2008
8-other
Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
PMID 18334606·Ann Pharmacother·2008
4-observational
GU radiation oncologists consensus on bone loss from androgen deprivation.
PMID 16515750·Can J Urol·2006
8-other
Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5.
PMID 16337128·Bioorg Med Chem·2006
7-preclinical
Successful pregnancy after amniotic fluid embolism: a case report.
PMID 16100626·J Obstet Gynaecol Can·2005
5-case
Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging.
PMID 16046689·Tob Control·2005
3-trial
Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori.
PMID 15937529·N Z Med J·2005
4-observational
Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4.
PMID 15911307·Bioorg Med Chem·2005
7-preclinical
Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
PMID 15868377·Invest New Drugs·2005
7-preclinical
Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid.
PMID 15670915·Bioorg Med Chem·2005
7-preclinical
Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
PMID 15367700·Mol Cancer Ther·2004
8-other
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
PMID 15173071·Clin Cancer Res·2004
7-preclinical
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
PMID 12893763·Blood·2003
7-preclinical
A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
PMID 12825938·J Med Chem·2003
7-preclinical
Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
PMID 12739061·Cancer Chemother Pharmacol·2003
7-preclinical
The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.
PMID 12584751·Int J Cancer·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4646 JOHN R ST
DETROIT, MI 48201 - Phone
- (313) 576-3233
Quick Facts
- NPI
- 1912223991
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile